Farrah Mateen

Associate Professor

Massachusetts General Hospital

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Ruth Dobson

UNITED KINGDOM

View details

Marie D'hooghe

Vrije Universiteit Brussel

BELGIUM

View details

Sini Laakso

FINLAND

View details

Shuhei Nishiyama

Assistant Professor

Tohoku University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Farrah Mateen

Research Interests

Explore related searches

Contact this professor

Articles (16)

Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss

Feasibility and tolerability of portable, low-field brain MRI for patients with multiple sclerosis

Impact of neuromyelitis optica spectrum disorder on employment and income in the United States

Nicolau syndrome following glatiramer acetate for multiple sclerosis: Case and review of reports

E = mc2: Education (E), medication (m), and conditional cash (c2) to improve uptake of antiseizure medications in a low‐resource population: Protocol for randomized trial

Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome

Rectifying global inequities in neuromyelitis optica diagnosis and treatment

Neurologic Care of Forcibly Displaced Persons

Perceptions of people with multiple sclerosis on social determinants of health: Mixed methods

Conditional cash transfers to improve health-focused outcomes: a global scoping review

Social determinants of health in multiple sclerosis

Progress towards the 2030 sustainable development goals: direct and indirect impacts on neurological disorders

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study

COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey

Low-dose rituximab should be used for treating MS in resource-limited settings: No

A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica

Collaborators (4)

Ruth Dobson

Marie D'hooghe

Sini Laakso

Shuhei Nishiyama

Make your next move.